Netanyahu’s ‘Obsession’ Helped Pfizer Choose Israel for Study

Photographer: Kobi Wolf/Bloomberg
Lock
This article is for subscribers only.

Sign up for our coming Middle East newsletter and follow us @middleeast for news on the region.

Pfizer Inc. chose Israel for a nationwide Covid-19 vaccination study, supplying enough shots to quickly inoculate the entire eligible population, after dozens of phone calls from its prime minister, sometimes in the middle of the night.